TMC Life Sciences suspends GCEO; appoints temporary replacement


TMC Life Sciences Bhd group CEO Dr Melvin Heng Jun Li

PETALING JAYA: TMC Life Sciences Bhd has appointed director Dr Melvin Heng Jun Li as its group chief executive officer (GCEO) with immediate effect, following the suspension of Wan Nadiah Wan Mohd Abdullah Yaakob.

In a filing with Bursa Malaysia, the company said Wan Nadiah was also suspended as CEO of Thomson Hospitals Sdn Bhd, resulting in the powers, authorities and functions vested in her as the GCEO and CEO to be suspended with effect from Jan 29, 2024 until further announcement by the board.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
TMC Life Sciences , CEO , Melvin Heng Jun Li ,

Next In Business News

Ringgit closes higher against greenback on cautious market sentiment
T7 Global subsidiary appointed panel contractor for PETRONAS
YTL inks RM200mil naming rights deal with Aviva for Bristol arena
KL High Court dismisses appeals of former Jalatama officers
Well Chip posts FY25 net profit jump to RM86.15mil
Angkasa targets 2026 revenue to reach up to RM75bil
Aeon Credit issues RM100mil five-year senior sukuk
Late bargain-hunting lifts Bursa Malaysia to end higher
Net foreign inflows into Malaysian bonds reach RM951.9mil in January - RAM Ratings
Wawasan Dengkil's 2Q net profit falls due to revision of project costs

Others Also Read